HeimLGND • NASDAQ
add
Ligand Pharmaceuticals Inc
117,28 $
Eftir lokun(0,00%)0,00
117,28 $
Lokað: 27. jan., 16:09:34 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
115,03 $
Dagbil
114,75 $ - 119,11 $
Árabil
67,72 $ - 129,90 $
Markaðsvirði
2,22 ma. USD
Meðalmagn
118,34 þ.
V/H-hlutf.
48,33
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 51,81 m. | 57,64% |
Rekstrarkostnaður | 32,73 m. | 42,98% |
Nettótekjur | -7,17 m. | 30,19% |
Hagnaðarhlutfall | -13,84 | 55,73% |
Hagnaður á hvern hlut | 1,84 | 80,39% |
EBITDA | 19,95 m. | 92,15% |
Virkt skatthlutfall | -13,14% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 219,64 m. | 15,30% |
Heildareignir | 954,87 m. | 24,13% |
Heildarskuldir | 113,69 m. | 12,20% |
Eigið fé alls | 841,18 m. | — |
Útistandandi hlutabréf | 18,90 m. | — |
Eiginfjárgengi | 2,57 | — |
Arðsemi eigna | 3,01% | — |
Ávöxtun eigin fjár | 3,36% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -7,17 m. | 30,19% |
Handbært fé frá rekstri | 36,53 m. | 377,77% |
Reiðufé frá fjárfestingum | -46,51 m. | -138,46% |
Reiðufé frá fjármögnun | 55,08 m. | 1.584,40% |
Breyting á handbæru fé | 45,48 m. | 629,64% |
Frjálst peningaflæði | 32,53 m. | 1.377,31% |
Um
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.
The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud.
In 2018 its CEO was listed among the top five highest paid CEOs in San Diego. Wikipedia
Stofnsett
sep. 1987
Vefsvæði
Starfsfólk
58
